Altered metabolism of growth hormone receptor mutant mice: A combined NMR metabonomics and microarray study

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Schirra, Horst Joachim ^a   Anderson, Cameron G ^a   Wilson, William J ^b   Kerr, Linda ^a   Craik, David J ^a   Waters, Michael J ^a   Lichanska, Agnieszka M ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CSIRO   (Australia)

^c TessArae LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; CHOLINE; CITRIC ACID; CREATINE; CREATININE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; LIPID; STAT5 PROTEIN; TAURINE; TRIMETHYLAMINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FATTY ACID OXIDATION; GENE EXPRESSION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIVER; LIVER METABOLISM; METABOLISM; METABONOMICS; MICROARRAY ANALYSIS; MOUSE; MOUSE MUTANT; MUTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; OBESITY; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; URINALYSIS; URINE LEVEL; WILD TYPE; ADIPOSE TISSUE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; DNA MICROARRAY; GENETICS; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

MUS;

ADIPOSE TISSUE; ANIMALS; INSULIN RESISTANCE; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLISM; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, SOMATOTROPIN; STAT5 TRANSCRIPTION FACTOR; TAURINE;

EID: 50649120799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002764     Document Type: Article

References (66)

1. Harvey S, Scanes CG, Daughaday WH (1995) Growth Hormone. Boca Raton: CRC Press Inc., pp 1-24, 39-54, 337-346, 351-370.
2. Bluher S, Kratzsch J, Kiess W (2005) Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract Res Clin Endocrinol Metab 19: 577-587.
3. Davidson MB (1987) Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8: 115-131.
4. Norrelund H, Nair KS, Jorgensen JO, Christiansen JS, Moller N (2001) The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes 50: 96-104.
5. Parini P, Angelin B, Rudling M (1999) Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler Thromb Vasc Biol 19: 832-839.
6. Richelsen B (1997) Action of growth hormone in adipose tissue. Horm Res 48 Suppl 5: 105-110.
7. Rudling M, Parini P, Angelin B (1999) Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans. Growth Horm IGF Res 9 Suppl A: 1-7.
8. Moller N, Jorgensen JO, Abildgard N, Orskov L, Schmitz O, et al. (1991) Effects of growth hormone on glucose metabolism. Horm Res 36 Suppl 1: 32-35.
9. Schuetz EG, Schuetz JD, May B, Guzelian PS (1990) Regulation of cytochrome P-450b/e and P-450p gene expression by growth hormone in adult rat hepatocytes cultured on a reconstituted basement membrane. J Biol Chem 265: 1188-1192.
10. Herrington J, Carter-Su C (2001) Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 12: 252-257.
11. Lichanska AM, Waters MJ (2007) How growth hormone controls growth, obesity and sexual dimorphism. Trends Genet 24: 41-47.
12. Bouillanne O, Rainfray M, Tissandier O, Nasr A, Lahlou A, et al. (1996) Growth hormone therapy in elderly people: an age-delaying drug? Fundam Clin Pharmacol 10: 416-430.
13. Ho KK, O'Sullivan AJ, Hoffman DM (1996) Metabolic actions of growth hormone in man. Endocr J 43 Suppl: S57-63.
14. Richelsen B (1999) Effect of growth hormone on adipose tissue and skeletal muscle lipoprotein lipase activity in humans. J Endocrinol Invest 22: 10-15.
15. Tollet-Egnell P, Flores-Morales A, Stahlberg N, Malek RL, Lee N, et al. (2001) Gene expression profile of the aging process in rat liver: normalizing effects of growth hormone replacement. Mol Endocrinol 15: 308-318.
16. Tollet-Egnell P, Parini P, Stahlberg N, Lonnstedt I, Lee NH, et al. (2004) Growth hormone-mediated alteration of fuel metabolism in the aged rat as determined from transcript profiles. Physiol Genomics 16: 261-267.
17. Olsson B, Bohlooly YM, Brusehed O, Isaksson OG, Ahren B, et al. (2003) Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes. Am J Physiol Endocrinol Metab 285: E504-511.
18. Flores-Morales A, Stahlberg N, Tollet-Egnell P, Lundeberg J, Malek RL, et al. (2001) Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology 142: 3163-3176.
19. Rowland JE, Lichanska AM, Kerr LM, White M, d'Aniello EM, et al. (2005) In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol 25: 66-77.
20. Nicholson JK, Wilson ID (1989) High-Resolution Proton Magnetic-Resonance Spectroscopy of Biological-Fluids. Progress in Nuclear Magnetic Resonance Spectroscopy 21: 449-501.
21. Nicholson JK, Lindon JC, Holmes E (1999)'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189.
22. Holmes E, Antti H (2002) Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst 127: 1549-1557.
23. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK, et al. (2004) Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res 14: 309-318.
24. Kiiveri HT (2008) A general approach to simultaneous model fitting and variable elimination in response models for biological data with many more variables than observations. BMC Bioinformatics 9: 195.
25. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
26. Holmes E, Foxall PJD, Spraul M, Farrant RD, Nicholson JK, et al. (1997) 750 MHz H-1 NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. Journal of Pharmaceutical and Biomedical Analysis 15: 1647-1659.
27. Connor SC, Wu W, Sweatman BC, Manini J, Haselden JN, et al. (2004) Effects of feeding and body weight loss on the H-1-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers 9: 156-179.
28. Tsuboyama-Kasaoka N, Shozawa C, Sano K, Kamei Y, Kasaoka S, et al. (2006) Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147: 3276-3284.
29. Voet D, Voet JG (2004) Biochemistry. New York: J. Wiley & Sons, 2 v. (xv, 1560 p.) p.
30. Fiehn O (2002) Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 48: 155-171.
31. Gavaghan CL, Holmes E, Lenz E, Wilson ID, Nicholson JK (2000) An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett 484: 169-174.
32. Nicholson JK, Holmes E, Lindon JC, Wilson ID (2004) The challenges of modeling mammalian biocomplexity. Nat Biotechnol 22: 1268-1274.
33. Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, et al. (2001) A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 19: 45-50.
34. Birdsall TC (1998) Therapeutic applications of taurine. Altern Med Rev 3: 128-136.
35. Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, et al. (2006) Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator or transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 20: 1333-1351.
36. Satoh H (1994) Cardioprotective actions or taurine against intracellular and extracellular calcium-induced effects. Adv Exp Med Biol 359: 181-196.
37. Timbrell JA, Waterfield CJ (1996) Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro. Adv Exp Med Biol 403: 125-134.
38. Mizushima S, Nara Y, Sawamura M, Yamori Y (1996) Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 403: 615-622.
39. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, et al. (1995) Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61: 1115-1119.
40. Kaisakia PJ, Jerkins AA, Goodspeed DC, Steele RD (1995) Cloning and Characterization of Rat Cysteine Sulfinic Acid Decarboxylase. Biochimica Et Biophysica Acta-Gene Structure and Expression 1262: 79-82.
41. Park E, Park SY, Wang CH, Xu J, LaFauci G, et al. (2002) Cloning of murine cysteine sulfinic acid decarboxylase and its mRNA expression in murine tissues. Biochimica Et Biophysica Acta-Gene Structure and Expression 1574: 403-406.
42. Asatoor AM, Simenhoff ML (1965) The origin of urinary dimethylamine. Biochim Biophys Acta 111: 384-392.
43. Baker JR, Chaykin S (1962) The biosynthesis of trimethylamine-N-oxide. J Biol Chem 237: 1309-1313.
44. Lang DH, Rettie AE (2000) In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms. Br J Clin Pharmacol 50: 311-314.
45. Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, et al. (1998) Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. Biochem Pharmacol 56: 1005-1012.
46. Clayton TA, Lindon JC, Everett JR, Charuel C, Hanton G, et al. (2004) Hepatotoxin-induced hypercreatinaemia and hypercreatinuria: their relationship to one another, to liver damage and to weakened nutritional status. Arch Toxicol 78: 86-96.
47. Bessman SP, Geiger PJ (1981) Transport of energy in muscle: the phosphorylcreatine shuttle. Science 211: 448-452.
48. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S (1983) Measurement of Muscle Mass in Humans - Validity of the 24-Hour Urinary Creatinine Method. American Journal of Clinical Nutrition 37: 478-494.
49. Simpson DP (1983) Citrate excretion: a window on renal metabolism. Am J Physiol 244: F223-234.
50. Norrelund H, Djurhuus C, Jorgensen JO, Nielsen S, Nair KS, et al. (2003) Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients. Am J Physiol Endocrinol Metab 285: E737-743.
51. Norrelund H, Moller N, Nair KS, Christiansen JS, Jorgensen JO (2001) Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis. J Clin Endocrinol Metab 86: 3120-3129.
52. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, et al. (1997) A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A 94: 13215-13220.
53. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
54. Cheng J, Sun S, Tracy A, Hubbell E, Morris J, et al. (2004) NetAffx Gene Ontology Mining Tool: a visual approach for microarray data analysis. Bioinformatics 20: 1462-1463.
55. Pandey R, Guru RK, Mount DW (2004) Pathway Miner: extracting gene association networks from molecular pathways for predicting the biological significance of gene expression microarray data. Bioinformatics 20: 2156-2158.
56. Braunschweiler L, Ernst RR (1983) Coherence Transfer by Isotropic Mixing - Application to Proton Correlation Spectroscopy. Journal of Magnetic Resonance 53: 521-528.
57. Rance M, Sorensen OW, Bodenhausen G, Wagner G, Ernst RR, et al. (1983) Improved Spectral Resolution in Cosy H-1-Nmr Spectra of Proteins Via Double Quantum Filtering. Biochemical and Biophysical Research Communications 117: 479-485.
58. Marion D, Wuthrich K (1983) Application of Phase Sensitive Two-Dimensional Correlated Spectroscopy (Cosy) for Measurements of H-1-H-1 Spin-Spin Coupling-Constants in Proteins. Biochemical and Biophysical Research Communications 113: 967-974.
59. Sklenar V, Piotto M, Leppik R, Saudek V (1993) Gradient-Tailored Water Suppression for H-1-N-15 Hsqc Experiments Optimized to Retain Full Sensitivity. Journal of Magnetic Resonance Series A 102: 241-245.
60. Bax A, Davis DG (1985) Mlev-17-Based Two-Dimensional Homonuclear Magnetization Transfer Spectroscopy. Journal of Magnetic Resonance 65: 355-360.
61. Palmer A, Cavanagh J, Wright P, Rance M (1991) Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy. Journal of Magnetic Resonance 93: 151-170.
62. Schleucher J, Schwendinger M, Sattler M, Schmidt P, Schedletzky O, et al. (1994) A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J Biomol NMR 4: 301-306.
63. Cavanagh J, Palmer AG, Wright PE, Rance M (1991) Sensitivity Improvement in Proton-Detected 2-Dimensional Heteronuclear Relay Spectroscopy. Journal of Magnetic Resonance 91: 429-436.
64. Cavanagh J, Chazin WJ, Rance M (1990) The Time-Dependence of Coherence Transfer in Homonuclear Isotropic Mixing Experiments. Journal of Magnetic Resonance 87: 110-131.
65. Norwood T, Boyd J, Heritage J, Soffe N, Campbell I (1990) Comparison of techniques for 1H-detected heteronuclear 1H - 15N Spectroscopy. Journal of Magnetic Resonance 87: 488-501.
66. Bax A, Summers M (19B6) H-1 and C-13 assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J Am Chem Soc 108: 2093-2094.